Featured
April 28, 2026
ASAP and MJFF announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.
Read More
In this blog, ASAP shares highlights from the 2025 Cell Biology of Parkinson’s Disease Conference that brought together investigators and trainees to discuss the intricacies of Parkinson’s disease at the cellular level.
Read More
In this blog, ASAP discusses the expansion of the CRN Cloud platform, which has grown to house over 50 harmonized multi-omics datasets while integrating new interoperability features and analysis tools to streamline collaboration across the Parkinson’s research community.
Read More
Guided by our open science approach, ASAP launched the Multi-Omics Meta-Analysis (MoMa) funding opportunity to support Collaborative Research Network (CRN) researchers interested in conducting meta-analysis of omics data housed within our publicly accessible database, the CRN Cloud.
Read More
The CRN — an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority research questions — occupies a unique and vital space in the research ecosystem. Rather than focusing on clinical trials or immediate drug testing, this network is dedicated to fundamental biology — the “early discovery” phase where the most transformative ideas are born.
Read More
This blog discusses how ASAP's latest investment aims to accelerate medical breakthroughs by creating a global, open-science toolkit of standardized resources and tools to overcome existing research barriers to overcome existing research barriers.
Read More
Parkinson’s News Today reports that the ASAP has awarded a $9 million grant to scientists from Cedars-Sinai, to investigate how exposure to specific pesticides and air pollutants interacts with genetic vulnerabilities to trigger the development of the disease.
View Story
Alzforum dives into the global scale of a $261 million investment by ASAP in partnership with The Michael J. Fox Foundation, which expands the Collaborative Research Network (CRN), to transform Parkinson's research by generating standardized tools and investigating the root causes of the disease.
View Story
The Guardian reports on a breakthrough study by CRN Team Schapira, which identified a distinct gut microbial "signature" that can signal Parkinson's risk years before physical symptoms appear.
View Story
Parkinson’s News Today reports that ASAP and The Michael J. Fox Foundation are investing $261 million to expand the Collaborative Research Network (CRN) to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies.
View Story
